Amphastar Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMPH Nasdaq 2836 www.amphastar.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amphastar Pharmaceuticals, Inc.

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks - Mar 13th, 2025 9:01 am
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference - Mar 5th, 2025 11:00 am
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers - Mar 5th, 2025 9:03 am
Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations - Mar 1st, 2025 12:36 pm
Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now? - Mar 1st, 2025 12:27 pm
Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds - Feb 28th, 2025 7:15 pm
Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Call Highlights: Revenue Growth and ... - Feb 28th, 2025 5:01 pm
Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Feb 27th, 2025 11:30 pm
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates - Feb 27th, 2025 11:15 pm
Amphastar: Q4 Earnings Snapshot - Feb 27th, 2025 10:23 pm
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1% - Feb 27th, 2025 10:02 pm
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024 - Feb 27th, 2025 9:05 pm
Amphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR outpaced the company's earnings growth over the same five-year period - Feb 26th, 2025 3:51 pm
Earnings To Watch: Amphastar Pharmaceuticals (AMPH) Reports Q4 Results Tomorrow - Feb 26th, 2025 1:17 pm
Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks - Feb 21st, 2025 9:07 am
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025 - Feb 20th, 2025 9:05 pm
Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest - Feb 19th, 2025 9:01 am
Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks - Feb 14th, 2025 9:01 am
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group - Feb 13th, 2025 9:01 am
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 8th, 2025 11:00 am